idoxuridine has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stearns, ME | 1 |
| Borre, M | 1 |
| Høyer, M | 1 |
| Sørensen, FB | 1 |
| Nerstrøm, B | 1 |
| Overgaard, J | 1 |
| Dostal, V | 1 |
| Fanta, D | 1 |
| Reiss-Gutfreund, RJ | 1 |
1 review available for idoxuridine and Cancer of Prostate
| Article | Year |
|---|---|
[Herpes simplex virus (hsv-1 and hsv-2) infection: its clinical and oncogenic properties (author's transl)].
Topics: Amantadine; Animals; Antibody Formation; Antigen-Antibody Complex; BCG Vaccine; Cell Transformation, | 1977 |
2 other studies available for idoxuridine and Cancer of Prostate
| Article | Year |
|---|---|
Taxol reduces circulating tumor cells to prevent bone metastases in SCID mice.
Topics: Animals; Bone Neoplasms; Cell Survival; Humans; Idoxuridine; Keratins; Male; Mice; Mice, SCID; Neopl | 1995 |
Association between in vivo iododeoxyuridine labeling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer.
Topics: Aged; Aged, 80 and over; Antigens, Nuclear; Cell Division; Humans; Idoxuridine; Ki-67 Antigen; Male; | 1998 |